Self-Monitoring OCT

May 7, 2026 updated by: Warren Sobol, Case Western Reserve University

Self-Monitoring Optical Coherence Tomography Device for Retinal Telehealth

The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician. Patients with ocular diseases often need to come to frequent appointments with an eye care provider for close monitoring and evaluation. Transportation difficulties, other medical problems, and limited appointments slots can make regular follow-up challenging. In addition, the anxiety of permanent vision loss and subjective nature of monitoring symptoms highlight the need for an alternative solution in which patients can self-generate OCT images of the eye for the eye care provider to review.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44106
        • University Hospitals Cleveland Medical Center
        • Principal Investigator:
          • Warren Sobol, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 1. Provision of signed and dated informed consent.
  • 2. Age ≥ 18 years.
  • 3. Presenting for care at a University Hospitals Eye Institute clinic
  • 4. Willing to complete study questionnaires.
  • 5. Scheduled to undergo standard technician-acquired OCT

Exclusion Criteria:

  • 1. Unable to provide informed consent or, in the judgment of study staff, unable to understand study procedures.
  • 2. Unable to cooperate with imaging or maintain stable positioning such that an evaluable OCT scan cannot be obtained (e.g., severe tremor or inability to maintain head position).
  • 3. Facial skin condition or open wound at the points of device contact that would make use of the headrest unsafe.
  • 4. Acute medical or ocular condition requiring immediate evaluation that, in the PI's judgment, precludes participation at that time.
  • 5. Any other condition that, in the opinion of the PI/designee, would place the participant at undue risk or compromise data quality (documented).
  • 6. Patients with visual acuity <20/200.
  • 7. Patients with significant media opacities precluding an OCT scan (posterior subcapsular cataract, vitreous hemorrhage, etc), or severe ptosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Self-administered OCT Images
Participants will use an OCT device to obtain OCT images of the eyes.
Self-administered OCT imaging using modified portable OCT with headrest and software workflow to enable patient self-operation and secure image transfer to a remote reading center.
Active Comparator: Technician-acquired OCT
Technicians will use a standard OCT device to obtain OCT images of the eyes as per standard of care.
Technician-acquired OCT obtained using routine clinical equipment during the same visit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of inner retinal abnormalities detected as measured by OCT images
Time Frame: Up to 60 minutes
Up to 60 minutes
Number of outer retinal abnormalities detected as measured by OCT images.
Time Frame: Up to 60 minutes
Up to 60 minutes
Sensitivity as measured by OCT images.
Time Frame: Up to 60 mins
Up to 60 mins
Specificity as measured by OCT images.
Time Frame: Up to 60 mins
Up to 60 mins
Positive predictive value (PPV) as measured by OCT images.
Time Frame: Up to 60 mins
Up to 60 mins
Negative predictive value (NPV) as measured by OCT images.
Time Frame: Up to 60 mins
Up to 60 mins

Secondary Outcome Measures

Outcome Measure
Time Frame
Image-quality as recorded by nurse coordinator during patient interaction with the device.
Time Frame: Up to 60 mins
Up to 60 mins
Number of successful completion of self-scans as recorded by nurse coordinator during patient interaction with the device.
Time Frame: Up to 60 mins
Up to 60 mins
Number of repeated attempts
Time Frame: Up to 60 mins
Up to 60 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Warren Sobol, MD, University Hospitals Cleveland Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

December 15, 2027

Study Completion (Estimated)

December 15, 2027

Study Registration Dates

First Submitted

May 7, 2026

First Submitted That Met QC Criteria

May 7, 2026

First Posted (Actual)

May 13, 2026

Study Record Updates

Last Update Posted (Actual)

May 13, 2026

Last Update Submitted That Met QC Criteria

May 7, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY20211004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obtaining OCT (Optical Coherence Tomography) Images

Clinical Trials on Self-administered OCT imaging system

Subscribe